You are here
- Home
- Therapy Areas
- Neuroscience
A single-centre, double blind, randomised, two-way cross-over study of repeated doses of AZD3480 and single dose of warfarin to evaluate the pharmacokinetic interaction of AZD3480 and warfarin and the effect of AZD3480 pharmacodynamic in healthy male subjects (phase I)
- Disease
- schizophrenia, Alzheimer's Disease
- Drug Name
- AZD3480
- Generic Name
- AZD3480
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Sep 19, 2007
- Study Name
- D3690C00014
- Study Id
- D3690C00014
- ClinicalTrials.gov ID
- NCT00689637
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
